Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder

por Yiğit Kaya, Süreyya, Askin, Abdullah Emre, Bektas, Sebnem, Çakır, Aslı, Gökmen Sevindik, Ömür
Publicado 2023

P1144: PHASE 2 WAVELINE-004 STUDY: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

por Ozcan, Muhit, Song, Yuqin, Tae Lee, Seung, Mensah, Felix, Modi, Dipenkumar, Fossa, Alexander, Seog Kim, Won, Paszkiewicz-Kozik, Ewa, Sawalha, Yazeed, Gokmen Sevindik, Omur, Norasetthada, Lalita, Santoro, Armando, Pathiraja, Kumudu, Chakraborty, Samhita, Marinello, Patricia, Lavie, David
Publicado 2023

P872: EFFICACY OF DARATUMUMAB PLUS BORTEZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA PRESENTING WITH EXTRAMEDULLARY DISEASE: A EUROPEAN MYELOMA NETWO...

por Beksac, Meral, Tuglular, Tulin, Gay, Francesca, Mina, Roberto, Katodritou, Eirini, Unal, Ali, Cavo, Michele, Hayri Ozsan, Guner, van der Velden, Vincent H.J., Beverloo, Berna, Vermeulen, Michael, van Duin, Mark, Cengiz, Guldane, Gokmen Sevindik, Omur, Merante, Serena, Manousou, Kyriaki, Sonneveld, Pieter, Terpos, Evangelos
Publicado 2023